InflaRx (IFRX) outlined multiple data analyses of the Phase 3 study for vilobelimab in pyoderma gangrenosum, which was terminated earlier this ...
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today reported positive results from a bias analysis conducted for its concluded Phase 3 study of Multikine (Leukocyte ...
Microsoft Excel’s Data Analysis Toolpak is an invaluable add-in for those who require complex statistical or engineering analyses. This powerful feature allows users to execute a variety of data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results